MISSISSAUGA, Ontario, Aug. 19, 2011 /PRNewswire via COMTEX/ --
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced that effective August 19, 2011, the company completed its previously announced acquisition of AB Sanitas (NASDAQ OMX: SAN1L).
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. More information about Valeant can be found at www.valeant.com.
Laurie W. Little